Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation
- PMID: 28583916
- PMCID: PMC5491304
- DOI: 10.1681/ASN.2017040451
Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation
Keywords: anticoagulation; apixaban; atrial fibrillation; dialysis; rivaroxaban.
Comment on
-
Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.J Am Soc Nephrol. 2017 Jul;28(7):2241-2248. doi: 10.1681/ASN.2016090980. Epub 2017 Mar 16. J Am Soc Nephrol. 2017. PMID: 28302754 Free PMC article.
References
-
- USRD System: 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2016
-
- You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY; American College of Chest Physicians: Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141[2 Suppl]: e531S–e575S, 2012 - PMC - PubMed
-
- Bonde AN, Lip GYH, Kamper A-L, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB: Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: A nationwide observational cohort study. J Am Coll Cardiol 64: 2471–2482, 2014 - PubMed
-
- Sood MM, Komenda P, Sood AR, Rigatto C, Bueti J: The intersection of risk and benefit: Is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis? Chest 136: 1128–1133, 2009 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources